NIVF vs EHAB

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Sep 26, 2026

NIVF

36.6
AI Score
VS
EHAB Wins

EHAB

49.9
AI Score

Investment Advisor Scores

NIVF

37score
Recommendation
AVOID NEW MONEY

EHAB

50score
Recommendation
HOLD

AI Analyst Insights

Detailed Metrics Comparison

Metric NIVF EHAB Winner
Forward P/E 0.0071 23.753 NIVF
PEG Ratio 0 0 Tie
Revenue Growth 11.9% 1.9% NIVF
Earnings Growth 0.0% 2.9% EHAB
Tradestie Score 36.6/100 49.9/100 EHAB
Profit Margin 209.0% -0.3% NIVF
Beta 1.00 1.00 Tie
AI Recommendation AVOID NEW MONEY HOLD EHAB

Relative Price Performance (Last 90 Days)

NIVF 1M: -92.4% · 3M: -78.1% EHAB 1M: +0.7% · 3M: +23.0%

Current Technical Phase

NIVF

Markdown
Sell / avoid

Price below a falling SMA50 (slope -16.1%), weak momentum, RSI 30

RSI (14): 29.6 · Price: $0.10

EHAB

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (5.0% over 20 days), RSI 62

RSI (14): 62.3 · Price: $13.80

Fundamentals Snapshot

Metric NIVF EHAB
Market Cap — —
Forward P/E 0.0 20.9
Trailing P/E 0.0 —
Revenue (TTM) — —
Revenue Growth 0.1% 0.0%
Gross Margin 0.2% 0.5%
Operating Margin -3.5% 0.0%
EPS 144.94 -0.07
Dividend Yield — —

Frequently Asked Questions

Based on our detailed analysis, EHAB is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.